Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2019

01-07-2019 | Original Article

Varied presentations and outcomes of Charcot neuroarthropathy in patients with diabetes mellitus

Authors: Ashu Rastogi, Mahesh Prakash, Anil Bhansali

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2019

Login to get access

Abstract

Charcot neuroarthropathy (CN) of the foot is uncommon and CN of atypical sites like wrist is sparingly described. CN is grossly under-diagnosed or misdiagnosed by primary care physicians. CN may present in acute phase with classical signs of inflammation or with deformities in chronic phase. The present study describes varied presentations, diagnostic dilemmas, and outcomes of CN in patients with diabetes. Data from the electronic repository of patients with diabetes and foot complications was obtained. The repository has a pre-designed structured format for information pertaining to the patients’ anthropometry, presentation, neurological, vascular and foot examination details, treatment offered, and outcomes on follow-up. In addition, literature search for prior reported cases of atypical site (wrist) of CN was conducted. Data of 206 subjects with foot CN and two cases of atypical joint amongst 1297 patients with diabetes mellitus was screened. The particulars of patients with varied presentation viz. acute phase (case 1), stable foot deformities in chronic phase (case 2), and unstable foot with destruction of ankle joint in hindfoot CN (case 3) are presented along with the differential diagnosis and their outcomes on follow-up at 36 months of presentation. A literature search for atypical site of CN revealed only nine cases of wrist CN. The diagnosis of wrist CN was not initially considered and misdiagnosed. Patient with CN may present in active phase or more commonly with deformities and destroyed joints. The acute CN is misdiagnosed as cellulitis and inadvertently treated with antibiotics. Wrist and MCP joint CN is extremely rare and the diagnosis of CN requires a high index of suspicion supported by radiography findings.
Literature
1.
go back to reference Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800.CrossRefPubMed Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800.CrossRefPubMed
3.
go back to reference Cavangh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care. 1994;17:201–9.CrossRef Cavangh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care. 1994;17:201–9.CrossRef
4.
go back to reference Bhansali A, Dutta P, Bhatt MH, Singh P, Aggrawal A, Mittal BR. The Charcot neuroarthropathy of the elbow in type 2 diabetes mellitus. Endocrinologist. 2009;19:171–3.CrossRef Bhansali A, Dutta P, Bhatt MH, Singh P, Aggrawal A, Mittal BR. The Charcot neuroarthropathy of the elbow in type 2 diabetes mellitus. Endocrinologist. 2009;19:171–3.CrossRef
5.
go back to reference Feldman MJ, Becker KL, Reefe WE, Longo A. Multiple neuropathic joints, including the wrist in a patient with diabetes mellitus. JAMA. 1969;209:1690–2.CrossRefPubMed Feldman MJ, Becker KL, Reefe WE, Longo A. Multiple neuropathic joints, including the wrist in a patient with diabetes mellitus. JAMA. 1969;209:1690–2.CrossRefPubMed
6.
go back to reference Bayne O, Lu EJ. Diabetic Charcot’s arthropathy of the wrist. Case report and literature review. Clin Orthop Relat Res. 1998;357:122–6.CrossRef Bayne O, Lu EJ. Diabetic Charcot’s arthropathy of the wrist. Case report and literature review. Clin Orthop Relat Res. 1998;357:122–6.CrossRef
7.
go back to reference Lambert PA, Close CF. Charcot neuroarthropathy of the wrist in type 1 diabetes. Diabetes Care. 2005;28:984–5.CrossRefPubMed Lambert PA, Close CF. Charcot neuroarthropathy of the wrist in type 1 diabetes. Diabetes Care. 2005;28:984–5.CrossRefPubMed
8.
go back to reference Wŕobel M, Szymborska-Kajanek A, Skiba M, et al. Charcot’s joint of the wrist in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2007;115:55–7.CrossRefPubMed Wŕobel M, Szymborska-Kajanek A, Skiba M, et al. Charcot’s joint of the wrist in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2007;115:55–7.CrossRefPubMed
9.
go back to reference Gökhan C¸ Erkan K¸ Levent Ö. Acute Charcot arthropathy of wrist in a diabetic patient. Rheumatol Int 2013 33:2959–2960.CrossRef Gökhan C¸ Erkan K¸ Levent Ö. Acute Charcot arthropathy of wrist in a diabetic patient. Rheumatol Int 2013 33:2959–2960.CrossRef
10.
go back to reference Illgner U, Netten JV, Droste C, Meiners T, Postema K, Wetz HH. Diabetic Charcot neuroarthropathy of the hand: clinical course, diagnosis and treatment options. Diabetes Care. 2014;37:e91–2.CrossRefPubMed Illgner U, Netten JV, Droste C, Meiners T, Postema K, Wetz HH. Diabetic Charcot neuroarthropathy of the hand: clinical course, diagnosis and treatment options. Diabetes Care. 2014;37:e91–2.CrossRefPubMed
11.
go back to reference Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot: current concepts and review of 36 cases. Scand J Surg. 2002;91:195–201.CrossRefPubMed Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot: current concepts and review of 36 cases. Scand J Surg. 2002;91:195–201.CrossRefPubMed
12.
go back to reference Sinha S, Munichoodappa C, Kozak GP. Neuroarthropathy Charcot’s joint in diabetes mellitus: a clinical study of 101 cases. Medicine (Baltimore). 1972;51:192–210.CrossRef Sinha S, Munichoodappa C, Kozak GP. Neuroarthropathy Charcot’s joint in diabetes mellitus: a clinical study of 101 cases. Medicine (Baltimore). 1972;51:192–210.CrossRef
13.
go back to reference Eichenholtz SN. Charcot joints. Springfield: Charles C, Thomas; 1966. p. 7–8. Eichenholtz SN. Charcot joints. Springfield: Charles C, Thomas; 1966. p. 7–8.
14.
go back to reference Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25:565–9.CrossRefPubMed Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25:565–9.CrossRefPubMed
15.
go back to reference Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.CrossRefPubMed Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.CrossRefPubMed
16.
go back to reference Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines. 4th edition. Pain Med. 2013;14:180–229.CrossRefPubMed Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines. 4th edition. Pain Med. 2013;14:180–229.CrossRefPubMed
17.
go back to reference Harden RN, Bruehl S, Perez RS, Birklein F, Marinus J, Maihofner C, et al. Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome. Pain. 2010;150:268–74.CrossRefPubMedPubMedCentral Harden RN, Bruehl S, Perez RS, Birklein F, Marinus J, Maihofner C, et al. Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome. Pain. 2010;150:268–74.CrossRefPubMedPubMedCentral
18.
go back to reference Charcot JM. Sur quelques arthropathies qui paraissent dépendre d’une lésion du cerveau ou de la moëlle épinière. Arch Physiol Norm Pathol. 1868;1:161–78. Charcot JM. Sur quelques arthropathies qui paraissent dépendre d’une lésion du cerveau ou de la moëlle épinière. Arch Physiol Norm Pathol. 1868;1:161–78.
19.
go back to reference Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307–58.CrossRef Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307–58.CrossRef
20.
go back to reference Chisholm KA, Gilchrist JM. The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13:1–13.CrossRefPubMed Chisholm KA, Gilchrist JM. The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13:1–13.CrossRefPubMed
21.
go back to reference Jeffcoate W, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis. 2004;39(Suppl 2):S115–22.CrossRefPubMed Jeffcoate W, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis. 2004;39(Suppl 2):S115–22.CrossRefPubMed
22.
go back to reference Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, et al. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55:32–5.CrossRefPubMed Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, et al. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55:32–5.CrossRefPubMed
23.
go back to reference Wang L, Shi X, Zhao R, Halloran BP, Clark DJ. Calcitonin- gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappa B activation, osteoclastogenesis and bone resorption. Bone. 2010;46:1369–79.CrossRefPubMed Wang L, Shi X, Zhao R, Halloran BP, Clark DJ. Calcitonin- gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappa B activation, osteoclastogenesis and bone resorption. Bone. 2010;46:1369–79.CrossRefPubMed
24.
go back to reference Ndip A, Williams A, Jude EB, Serracino-Inglott F. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60:2187–96.CrossRefPubMedPubMedCentral Ndip A, Williams A, Jude EB, Serracino-Inglott F. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60:2187–96.CrossRefPubMedPubMedCentral
25.
go back to reference Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44:2032–7.CrossRefPubMed Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44:2032–7.CrossRefPubMed
26.
go back to reference Pakarinen T-K, Laine H-J, Maenpaa H, Mattila P, Lahtela J. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy. Diabetes Care. 2011;34:1514–6.CrossRefPubMedPubMedCentral Pakarinen T-K, Laine H-J, Maenpaa H, Mattila P, Lahtela J. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy. Diabetes Care. 2011;34:1514–6.CrossRefPubMedPubMedCentral
27.
go back to reference Richard JL, Almasari M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. 2012;55:1258–64.CrossRefPubMed Richard JL, Almasari M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. 2012;55:1258–64.CrossRefPubMed
Metadata
Title
Varied presentations and outcomes of Charcot neuroarthropathy in patients with diabetes mellitus
Authors
Ashu Rastogi
Mahesh Prakash
Anil Bhansali
Publication date
01-07-2019
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0700-8

Other articles of this Issue 3/2019

International Journal of Diabetes in Developing Countries 3/2019 Go to the issue